A randomized, double-blind, placebo-controlled study involved 81 volunteers aged 45–65 years, particularly susceptible to aging effects due to stressful jobs.
Over a 12-week period, participants taking 100 mg of EPIGEN12™ demonstrated:
- Improved Leukocyte Telomere Length (LTL): A crucial indicator of cellular aging.
- Enhanced Quality of Life (QOL): Including significant improvements in physical activity and sleep indices compared to placebo.
- Prevention of Epigenetic Aging: Slowing biological aging, in contrast to the placebo group, which experienced an increase.
All participants tolerated the supplement well, with no adverse effects reported.













































You must be logged in to post a review.